tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
Concert Pharmaceuticals's activity chart (see below) currently has 62 price targets and 52 ratings on display.
Analysts average stock forecasts to be materialized ratio is 20.33% with an average time for these price targets to be met of 206.24 days.
Most recent stock forecast was given by STEPHEN KIM from EVERCORE on 20-Jan-2023. First documented stock forecast 08-Jul-2014.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$17
3 years 8 months 8 days ago
(20-Jan-2023)
0/1 (0%)
$10.12 (147.09%)
Buy
$25
3 years 8 months 9 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Hold Since 19-Jan-2023
$25
3 years 8 months 9 days ago
(19-Jan-2023)
0/6 (0%)
$18.01 (257.65%)
Buy Since 04-Sep-2019
$11
$2.63 (31.42%)
$25
4 years 4 months 5 days ago
(23-May-2022)
0/5 (0%)
$6.9 (168.29%)
Buy Since 24-Jul-2017
$17
$8.63 (103.11%)
$17
4 years 4 months 5 days ago
(23-May-2022)
1/7 (14.29%)
$12.9 (314.63%)
115
What is CNCE (Concert Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on CNCE (Concert Pharmaceuticals)?
Which analyst has the most public recommendations on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most bullish on CNCE (Concert Pharmaceuticals)?
Which analyst is the currently most reserved on CNCE (Concert Pharmaceuticals)?
